Satyanarayana Chava – Founder And Ceo At Laurus Labs
View Detailed Executive Profile →Professional Overview
- Satyanarayana Chava founded Laurus Labs in 2005 and has been instrumental in its transformation into a leading integrated pharmaceutical company.
- Under his leadership, Laurus Labs has achieved significant growth and innovation in the pharmaceutical industry, focusing on providing high-quality solutions.
- Chava holds both a master's degree and a Ph.D. in chemistry, showcasing his strong academic background that supports his expertise in the pharmaceutical field.
- In March 2024, he received the Best CEO Award in Pharma & Health Care from Business Today, reflecting his leadership excellence in the industry.
- He has overseen numerous strategic initiatives that enhanced Laurus Labs’ capabilities in manufacturing and research and development of pharmaceutical products.
- Chava has contributed to expanding the company's global presence, successfully navigating competitive challenges in the pharmaceutical sector.
- His vision for Laurus Labs includes continuous improvement, sustainability in operations, and a commitment to enhancing patient outcomes worldwide.
Professional Experience
| Company | Designation | Period |
|---|---|---|
| Matrix Laboratories Ltd | COO | Aug 1995 – Jun 2005 |
| S3v Vascular Technologies Limited | Director | 30 Sep 2013 – 07 August 2015 |
| Laurus Labs | Founder and CEO | Sep 2005 – Present |
| Nowpos M-Solutions Private Limited | Director | 31 Dec 2005 – Present |
| Pharmaceuticals Export Promotion Council Of India | Director | 25 Apr 2018 – Present |
| Laurus Labs Limited | Whole-time director | 21 Jan 2006 – Present |
| Laurus Bio Private Limited | Director | 20 Jan 2021 – Present |
| Krka Pharma Private Limited | Director | 12 Apr 2024 – Present |
| Chemiasoft Private Limited | Director | 10 Jan 2014 – Present |
| Immunoadoptive Cell Therapy Private Limited | Nominee Director | 09 Dec 2021 – Present |
Current Appointments
| CIN/LLP | Company | Designation | Date |
|---|---|---|---|
| L24239AP2005PLC047518 | Laurus Labs Limited | Whole-time director | 21 Jan 2006 |
| U02423KA2005PTC036770 | Laurus Bio Private Limited | Director | 20 Jan 2021 |
| U21000TS2024FTC184449 | Krka Pharma Private Limited | Director | 12 Apr 2024 |
| U24239TG2004NPL043058 | Pharmaceuticals Export Promotion Council Of India | Director | 25 Apr 2018 |
| U72200TG2005PTC046163 | Nowpos M-Solutions Private Limited | Director | 31 Dec 2005 |
| U72300TG2014PTC092281 | Chemiasoft Private Limited | Director | 10 Jan 2014 |
| U74999MH2018PTC315497 | Immunoadoptive Cell Therapy Private Limited | Nominee Director | 09 Dec 2021 |
Previous Appointments
| CIN/LLP | Company | Designation | Period |
|---|---|---|---|
| U33112KA2011PLC059915 | S3v Vascular Technologies Limited | Director | 30 Sep 2013 – 07 August 2015 |
Estimated Net Worth
Estimated Range: ₹0 – ₹1000+ Cr (approx. $0 – $120M+)
Based on publicly accessible filings, industry benchmarks, and leadership compensation patterns.
Executive Contact
Official Email: Via Founder And Ceo At Laurus Labs corporate communication desk.
Personal Contact: Not publicly disclosed.
Frequently Asked Questions
What is Satyanarayana Chava's net worth?
Estimated ₹0 – ₹1000+ Cr (approx. $0 – $120M+).
How can I contact them?
Through Founder And Ceo At Laurus Labs's official communication channels.
Is this an official profile?
No — independently created using public data.
Disclaimer
This profile is created for general informational purposes. All details are based on publicly accessible information and independent research. While accuracy is prioritized, content may not always reflect the latest updates.
Nothing here should be interpreted as investment, financial, or legal advice. The individual featured has not authored or endorsed this profile.
Personal information is intentionally withheld. For official matters, please use formal communication channels associated with the respective organization.
Affluense AI – Smarter Insights. Stronger Relationships with Affluents.
Last Updated: December 2025 · Published by Affluense AI (affluense.ai)